A group of weight loss and diabetes treatment drugs, known as GLP-1 agonists, work by curbing appetite centers in the brain. But animal studies suggest these drugs could also potentially reduce addiction to nicotine, alcohol, and opioids. Dr. Jon LaPook explains.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
